French develop prototype radiotherapy device
This article was originally published in Clinica
A French company is negotiating with potential manufacturers for the development of a prototype radiotherapy device that could revolutionise cancer treatment, especially for difficult to reach tumours. Pantechnik, based in Caen, has designed a device that would make proton radiotherapy more widely available, which is a more accurate treatment than the conventionally available high-energy X-ray (or photon) therapy.
You may also be interested in...
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.
Duo will study up to four novel preclinical targets identified by Sitryx that may lead to potential new drugs for autoimmune diseases, which Lilly would then commercialize.